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Abstract
Background: Metabolic reconstruction of microbial, plant and animal genomes is a necessary step
toward understanding the evolutionary origins of metabolism and species-specific adaptive traits.
The aims of this study were to reconstruct conserved metabolic pathways in the cattle genome and
to identify metabolic pathways with missing genes and proteins. The MetaCyc database and
PathwayTools software suite were chosen for this work because they are widely used and easy to
implement.
Results: An amalgamated cattle genome database was created using the NCBI and Ensembl cattle
genome databases (based on build 3.1) as data sources. PathwayTools was used to create a cattle-
specific pathway genome database, which was followed by comprehensive manual curation for the
reconstruction of metabolic pathways. The curated database, CattleCyc 1.0, consists of 217
metabolic pathways. A total of 64 mammalian-specific metabolic pathways were modified from the
reference pathways in MetaCyc, and two pathways previously identified but missing from MetaCyc
were added. Comparative analysis of metabolic pathways revealed the absence of mammalian genes
for 22 metabolic enzymes whose activity was reported in the literature. We also identified six
human metabolic protein-coding genes for which the cattle ortholog is missing from the sequence
assembly.
Conclusion: CattleCyc is a powerful tool for understanding the biology of ruminants and other
cetartiodactyl species. In addition, the approach used to develop CattleCyc provides a framework
for the metabolic reconstruction of other newly sequenced mammalian genomes. It is clear that
metabolic pathway analysis strongly reflects the quality of the underlying genome annotations.
Thus, having well-annotated genomes from many mammalian species hosted in BioCyc will facilitate
the comparative analysis of metabolic pathways among different species and a systems approach to
comparative physiology.
Background
Production of domesticated cattle (Bos taurus and Bos indi-
cus) accounts for 7% of the total food consumption in the
world [1] and contributes 17.0% of all farm cash receipts
in the United States [2]. Thus, there has been a strong
rationale for developing genomic resources that can be
used to increase the rate of genetic improvement for milk
and meat production, disease resistance, feed efficiency
and reproductive performance. Understanding the biol-
ogy of cattle, particularly the unique features of ruminant
metabolism [3], is a prerequisite for the sustainability of
the cattle industry. However, many gaps still exist in our
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understanding of ruminant metabolism and many other
traits specific to cetartiodactyl mammals [4]. The recent
sequencing of the cattle genome [5] provides the first
opportunity to systematically link genetic and metabolic
traits of cattle and other ruminants.
Genome-scale models are useful to analyze, interpret and
predict the genotype-to-phenotype relationships in an
organism [6]. Accordingly, there have been attempts to
reconstruct genome-scale metabolic pathways for a variety
of organisms, including bacteria [7], simple eukaryotes
[8] and higher eukaryotes [9-11]. For example the Path-
way Tools software package [12] has been used to generate
organism-specific pathway genome databases (PGDBs)
for bacteria [13], plants [14,15] and animals [9]. Using
the PathoLogic algorithm [16], Pathway Tools computa-
tionally reconstructs organism-specific metabolic path-
ways and generates a new PGDB by matching the Enzyme
Commission (EC) number and/or the name of the anno-
tated gene product against enzymes in MetaCyc, a manu-
ally curated database containing over 900 pathways from
more than 900 different organisms [17]. BioCyc http://
biocyc.org is a collection of more than 260 PGDBs gener-
ated using Pathway Tools followed by manual curation
[18]. Among the mammals, PGDBs in BioCyc exist only
for human and recently for mouse.
For the cattle reference genome assembly build 3.1, inde-
pendent sets of gene models and annotations are availa-
ble from the National Center for Biotechnology
Information (NCBI) [19] and from Ensembl [20]. Both
are dependent on sequence similarity of cattle proteins to
homologs in other well-annotated organisms (e.g. human
and mouse). Thus, there is now an opportunity to recon-
struct bovine metabolism using these resources. For this,
we developed an amalgamated cattle genome database
from the NCBI and Ensembl gene models that incorpo-
rates all the available functional annotation information
for cattle genes and proteins from other data sources.
Metabolic pathways were then identified using Pathway
Tools and the reconstructed pathways of cattle were com-
pared to those of other organisms. We also corrected and
updated mammalian-specific metabolic pathways in Met-
aCyc, and identified enzymes not associated to genes.
Results
The amalgamated cattle genome annotation database
At the time of the present analysis, 28,732 and 25,132
genes in the cattle genome were predicted in the NCBI and
Ensembl genome databases, respectively. For the two gene
sets only 2,109 genes had exactly the same gene coordi-
nates, and 6,479, 16,163, 7,026 and 1,360 genes had a
common gene symbol, Entrez-Gene ID, gene product
name, or EC number, respectively (Table 1).
By sequential one-to-one matching, a total of 16,173 con-
sensus gene models were identified. A total of 2,109 genes
had exactly the same gene coordinates; the rest of the
matching criteria sequentially identified 5,187 (gene sym-
bol), 8,800 (Entrez-Gene ID), 71 (gene product name)
and 6 (EC number) consensus gene pairs (Table 1).
When Entrez-Gene ID was used as the last matching crite-
rion in the matching sequence, no difference in the total
number of consensus genes was observed. Among the
gene pairs that shared some portion of their gene coordi-
nates and had the same "gene type" and coding strand,
2,276 were not considered as matches on the basis of the
remaining matching criteria. During the manual curation
of cattle PGDB, 27 gene pairs with overlapping coordi-
nates that were classified as a different "gene type" in the
NCBI and Ensembl databases were added back to cattle
PGDG as consensus gene pairs. The amalgamated cattle
genome database thus contains 16,200 (16,173 + 27)
consensus cattle genes and has 12,287 and 8,932 genes
contained exclusively in NCBI build 3.1 or Ensembl build
3.1, respectively (Table 2). In addition, 245 genes from
NCBI genome scaffolds that were not incorporated into
genome build 3.1 were included in the final build of the
amalgamated cattle genome database.
Amalgamated databases were also constructed for human,
mouse and dog. The sequential matching process identi-
fied a total of 19,354, 20,118 and 14,147 genes in the
NCBI and Ensembl databases for human, mouse and dog,
respectively [see Additional file 1].
Metabolic reconstruction of the cattle genome
The general scheme of the metabolism-centered approach
used for metabolic reconstruction of the cattle genome is
shown in Figure 1. The initial automated construction of
Table 1: The number of consensus cattle gene pairs in the NCBI 
and Ensembl cattle genome databases
Type of match Number of pairs† Unique matches‡
Same gene coordinates 2,109 2,109
Gene symbol 6,479 5,187
Entrez gene ID 16,163 8,800
Gene product name 7,026 71
E.C. number 1,360 6
Manual* N.A. 27
Total 33,137 16,200
Not matched 2,276 2,276
†The total number of matches using each criterion; one-to-one match 
was not assumed.
‡Number in each row is sequential for the match criteria given under 
"number of pairs", in addition to the matches for the criteria 
immediately above; only one-to-one matches were considered.
*Manually matched because the consensus genes were classified into 
different 'gene type' (e.g. protein coding, pseudogene, tRNA and 
miscellaneous RNA) in the NCBI and Ensembl gene models.BMC Systems Biology 2009, 3:33 http://www.biomedcentral.com/1752-0509/3/33
Page 3 of 13
(page number not for citation purposes)
cattle PGDB using the PathoLogic algorithm recognized
1,008 and 164 enzymes (gene products) by EC number
and gene product name matching, respectively. These
were involved in 873 unique enzymatic reactions. The ini-
tial build of the cattle PGDB contained 243 metabolic
pathways, 1,528 reactions, including 1,500 enzymatic, 25
spontaneous and 3 transport reactions, and 1,116 com-
pounds (Table 3). An enzymatic reaction was defined as a
chemical reaction that involves a single enzyme or an
enzyme complex but does not mediate molecular trans-
port. Because not all enzymatic reactions were incorpo-
rated into metabolic pathways, 1,059 out of 1,528
reactions and 473 out of 1,172 genes were present in the
initial build of the cattle PGDG metabolic pathways. As
shown in Table 3, 184 metabolic pathways contained one
or more pathway holes, which are defined as reactions in
which the organism-specific enzyme has not yet been
identified. The total number of pathway holes was 593, or
56% of the total known reactions in pathways.
For comparison, the same approach used for the initial
metabolic reconstruction of the cattle genome (Figure 1)
was used for metabolic reconstruction of the human,
mouse and dog genomes. The automated reconstructions
identified 342, 324 and 151 metabolic pathways for
human, mouse and dog genomes, respectively (Table 3).
The larger number of predicted metabolic pathways in
human and mouse compared to dog is mainly because the
current annotation of the human and mouse genomes is
more extensive than that of the dog genome. A relatively
large percentage of reactions in pathways are in pathway
holes; 45% in human and 43% in mouse. For dog, 67%
of genes encoding enzymes in known pathways were not
identified in the current annotation.
To improve metabolic reconstruction of the cattle and
other mammalian genomes we manually reviewed 553
metabolic pathways present in HumanCyc, EcoCyc and
also predicted in the automated reconstructions for
human, mouse and dog. Out of the 243 automatically
reconstructed cattle pathways, 79 pathways were deleted
because previous biochemical evidence for these pathways
existed only in microbes or plants. Fifty-one reference path-
ways from MetaCyc were modified manually in CattleCyc
because they did not adequately represent mammalian
metabolic pathways according to literature sources. After
curation, these were added to the cattle PGDB.
Additionally, 15 more mammalian metabolic pathways
were created manually and 38 pathways from MetaCyc,
which were not included in the initial reconstruction
mainly due to incomplete annotation of the cattle
genome, were also added manually. Consequently, the
curated cattle PGDB contains 113 pathways from the
automated reconstruction and 104 pathways that were
manually added (Figure 2). A listing of the 66 new manu-
ally curated mammalian metabolic pathways created in
CattleCyc is given [see Additional file 2].
Table 2: Distribution of genes in the amalgamated cattle 
genome database according to the original data sources
Source Number of genes
Consensus build 3.1 (this study) 16,200
NCBI build 3.1 only 12,287
Ensembl build 3.1 only 8,932
NCBI other genome scaffolds* 245
Total 37,664
*Scaffolds not incorporated into NCBI genome build 3.1, including 
some scaffolds from the reference assembly build 2.1.
Table 3: Comparison of selected organism-specific pathway genome databases (PGDB)
Database statistics Cattle New PGDB without manual curation BioCyc
Initial Curated Human Mouse Dog E. coli Human
Metabolic pathways 243 217 342 324 151 194 178
Enzymatic reactions 1,500 1,419 2,020 1,941 1,102 1,245 1,253
Enzymes 1,172 1,544 2,846 2,789 753 1,323 2,594
Compounds 1,116 1,021 1,390 1,325 794 1,202 975
Pathway holes (missing enzymes)
number of pathway holes 593 113 587 536 509 35 246
pathway holes as a percentage of total reactions in pathways 56% 14% 45% 43% 67% 5% 36%
pathways with no holes 59 165 134 128 17 169 67
pathways with 1 hole 51 28 64 65 30 15 35
pathways with 2 holes 32 11 40 41 22 7 37
pathways with 3 holes 21 1 36 25 15 3 15
pathways with 4 holes 14 6 18 18 15 0 11
pathways with >5 holes 66 6 50 47 52 0 13
total pathways with holes 184 52 208 196 134 25 111BMC Systems Biology 2009, 3:33 http://www.biomedcentral.com/1752-0509/3/33
Page 4 of 13
(page number not for citation purposes)
The metabolism-centered approach used for the identification of metabolic pathways and "missing" enzymes Figure 1
The metabolism-centered approach used for the identification of metabolic pathways and "missing" enzymes. 
Solid and dashed arrows represent data and information flows, respectively.BMC Systems Biology 2009, 3:33 http://www.biomedcentral.com/1752-0509/3/33
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The manually curated version of CattleCyc consists of 217
metabolic pathways that contain 736 genes involving 825
distinct enzymatic reactions. CattleCyc contains 1,544
enzymes in 1,277 known enzymatic reactions, 1,442 bio-
chemical reactions including 1,419 enzymatic reactions,
and 1,021 compounds (Table 3). At the time of writing
the total number of genes having an annotated EC
number in CattleCyc is 1,500, which is larger than 1,263
found in KEGG (Genome Database Release 07-07-26)
and 1,346 in UniProt (Knowledgebase Release 12.0). A
total of 113 pathway holes were present among 52 path-
ways in the manually curated version of the database. The
total number of pathway holes as a percentage of total
reactions in pathways is 14%, which is higher than Eco-
Cyc (5%), but lower than the existing version of Human-
Cyc (36%).
Among 113 missing enzyme genes in the cattle metabolic
pathways, the activities of six enzymes were reported in
cattle (Table 4) [21-38]; 16 enzyme activities were
reported in other mammals but not in cattle (Table 5) [39-
67]. However, in both cases, corresponding mammalian
genes have not been identified. Interestingly, no enzy-
matic activity for L-ascorbate peroxidase has been
reported in any mammal, except for cattle. For six
enzymes, the cattle orthologs of human genes ECGF1,
CERK,  FAAH2,  ALG12  and  EARS2  were not identified
(Table 6). Neither a gene nor enzyme activity was identi-
fied for the other pathway holes; however, the pathways
remain in the database because there is some evidence
that they are present in mammals even though not all the
reactions in the pathways have been validated.
The pathways contained in CattleCyc were compared with
those in EcoCyc [13] and HumanCyc [9] (Figure 3). The
consensus pathways among these databases were identi-
fied at both the enzyme (enzymes with the same EC num-
bers) and functional levels (a pathway that has the same
biological function but individual enzymes may vary and
alternative reactions may exist). Among the metabolic
pathways contained in CattleCyc, EcoCyc and HumanCyc
(Table 3), 31 and 47 pathways are shared at the enzyme
and functional levels, respectively. There was one cattle-
specific pathway identified (ascorbate biosynthesis), and
a relatively small fraction of pathways were common
between CattleCyc and HumanCyc (Figure 3). The limited
degree of pathway sharing between the cattle and human
databases is mainly because, despite intensive manual
curation of HumanCyc [9], many pathways were deleted
or manually revised in CattleCyc [see Additional file 3].
Comparative analysis of metabolic pathways in CattleCyc
and EcoCyc indicates that enzymes involved in some
pathways are highly conserved, including tRNA charging,
nucleotide sugar biosynthesis, pyrimidine ribonucleotide
biosynthesis, fatty acid β-oxidation and biosynthesis, gly-
cogen degradation, coenzyme A biosynthesis, folate poly-
glutamylation, non-oxidative pentose phosphate
pathway, and pyridoxal 5'-phosphate salvage pathway
[see Additional file 4]. These pathways all involve more
than five enzymatic reactions.
Discussion
The amalgamated cattle genome annotation database
There are collaborative efforts to identify a core set of pro-
tein coding regions that are consistently annotated in
human and mouse [68]. Likewise, this is a goal of the
Bovine Genome Sequencing Consortium [5]. Herein, we
have attempted to resolve annotation discrepancies
between NCBI and Ensembl for the cattle genome. In
order to obtain a non-redundant gene set, HumanCyc [9]
used Ensembl Build 31 as the main data source for anno-
tation and merged Ensembl and Entrez genes if Ensembl
included a cross reference to the Entrez-Gene ID. This
approach, however, had a systematic problem when
applied to the cattle genome. A total of 20,480 cattle Ent-
rez-Gene ID were cross-referenced to 16,921 cattle genes
in Ensembl. Out of these, 14,733 Ensembl genes had only
one Entrez-Gene ID, whereas 1,649 and 539 genes con-
tained 2 and >3 Entrez-Gene IDs, respectively. When each
NCBI gene was paired with a corresponding Ensembl gene
that had the same Entrez-Gene ID, a total of 20,443 gene
pairs were obtained. Among those gene pairs, "gene type"
and "coding strand" were not matched between NCBI and
Ensembl for 1,245 and 1,693 cattle gene pairs, respec-
tively. Surprisingly, gene coordinates did not overlap for
3,523 pairs although the same Entrez-Gene ID was
assigned. Among those gene pairs for which both NCBI
and Ensembl had an assigned gene symbol (8,093 pairs)
Comparison of constructed metabolic pathways by automa- tion with those after manual curation Figure 2
Comparison of constructed metabolic pathways by 
automation with those after manual curation. Num-
bers of metabolic pathways, shared by the cattle pathway 
genome database (PGDB) generated computationally and 
after manual curation. The numbers in parentheses are the 
total number of pathways in the corresponding cattle PGDB.BMC Systems Biology 2009, 3:33 http://www.biomedcentral.com/1752-0509/3/33
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or gene product name (10,188 pairs), 19% and 30% were
assigned inconsistent gene symbols or gene product
names, respectively. Therefore, finding a consensus gene
set on the basis of multiple criteria and a sequential
matching process is necessary and more reliable than
using a single criterion.
Even using the above process, there were several cases for
which matching "gene type" produced an unreliable
result. For example, some protein coding genes in
Ensembl were classified as 'pseudogenes' in NCBI, and a
total of 54 genes in NCBI had the "gene type" of
'unknown' or 'other', which were not present in Ensembl
gene classifications. In the amalgamated cattle database,
10 and 17 genes that were classified as 'pseudogenes' and
'unknown' or 'other', respectively; in NCBI they were
found to be involved in enzymatic reactions. These were
manually reclassified as protein coding genes and merged
with the corresponding Ensembl genes. More unidenti-
fied consensus genes may be present in our database due
to differences in "gene type" annotations in the Ensembl
and NCBI databases.
We developed an amalgamated genome database that
includes all the gene models predicted by Ensembl and
NCBI. Our approach has several advantages. First, the
amalgamated database likely contains most cattle genes.
The Ensembl and NCBI gene models predict genes that are
independently supported by multiple lines of biochemi-
cal and computational evidence. Therefore, there is pres-
ently insufficient evidence to reject the presence of genes
predicted by either source. An amalgamated gene predic-
tion set is thus expected to be more complete. For exam-
ple, among those genes that were identified to encode
enzymes for the known reactions in our database, 112 and
79 genes were predicted exclusively by Ensembl or NCBI,
respectively. Another advantage of the amalgamation
approach is that all available functional annotations of
cattle genes can be easily incorporated into the final prod-
uct, because the additional step of informatically linking
Table 4: List of enzyme activities reported in cattle and other mammals that do not have a mammalian gene identified
Pathway Enzyme name EC number* Mammalian species
Ascorbate glutathione cycle L-ascorbate peroxidase† 1.11.1.11 cattle [21]
4-hydroxyproline degradation 4-hydroxy-2-oxoglutarate aldolase 4.1.3.16 cattle [27-30], rat [22]
Ascorbate biosynthesis gluconolactonase 3.1.1.17 cattle [23,25], pig [35]
Ascorbate biosynthesis uronolactonase 3.1.1.19 cattle [37], pig [37], rabbit [37], monkey [37], dog [37], guinea 
pig [37], rat [33,37]
γ-glutamyl cycle γ-glutamyl cyclotransferase 2.3.2.4 cattle [26], human [38], rat [34], mouse [24], pig [36]
Selenocysteine biosynthesis selenocysteine synthase 2.9.1.1 mouse [32], cattle [31]
*Enzyme Commission number
†Partial sequence of the protein is known (UniProt: Q7M3G0)
Table 5: List of metabolic enzyme activities without an identified mammalian gene
Pathway Enzyme name EC number* Mammalian species
4-hydroxyproline degradation 4-oxoproline reductase 1.1.1.104 human [56], rabbit [56]
Ascorbate biosynthesis glucuronolactone reductase 1.1.1.20 rat [48,54]
Ascorbate biosynthesis 1,4-lactonase 3.1.1.25 human [45,94], rat [45,94]
β-alanine biosynthesis 3-hydroxypropionate dehydrogenase 1.1.1.59 pig [43], chicken [43]
β-alanine biosynthesis β-alanine-pyruvate transaminase 2.6.1.18 rat [49]
Cysteine degradataion hypotaurine dehydrogenase 1.8.1.3 rat [57]
Degradation of purine deoxyribonucleosides phosphopentomutase 5.4.2.7 human [58], rabbit [58], rat [40,58]
Glutathione detoxification cycteine-S-conjugate N-acetyltransferase 2.3.1.80 human [47], rat [44,47], pig [39,51]
Histidine degradation histidine aminotransferase 2.6.1.38 mouse [41]
Lysine degradation pyrroline-2-carboxylate reductase 1.5.1.1 mouse [46], dog [46], rat [52]
Lysine degradation L-lysine oxidase 1.4.3.14 mouse [53]
Purine degradation guanosine deaminase 3.5.4.15 human [50], Rat [42]
Pyridine nucleotide cycling nicotinamidase 3.5.1.19 mouse [59], rat [55], rabbit [55,60,61]
Tryptophan degradation aminomuconate-semialdehyde 
dehydrogenase
1.2.1.32 cat [64]
UDP-N-acetylgalactosamine biosynthesis UDP-N-acetylglucosamine 4-epimerase 5.1.3.7 human [62,67], rat [63], pig [66]
Valine degradation pyruvate decarboxylase 4.1.1.1 human [65]
*Enzyme Commission numberBMC Systems Biology 2009, 3:33 http://www.biomedcentral.com/1752-0509/3/33
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IDs of the consensus gene set to KEGG, UniProt and other
databases is not necessary.
Metabolic reconstruction of the cattle genome
Although there are several bioinformatic platforms that
could be used in reconstruction of genome-scale organ-
ism-specific metabolic networks, Pathway Tools has
advantages over others in that 1) the Pathway Tools soft-
ware allows automated and user-friendly generation of an
organism-specific pathway database. PathoLogic permits
mapping the functional annotation of gene products into
MetaCyc, one of the largest, most comprehensive and
well-curated databases for biochemical pathways; 2) cur-
rently, more than 260 PGDBs have been generated using
Pathway Tools and the common 'Cyc' database format,
which provides a consistent platform for the comparative
analysis of metabolic pathways among different species
[15]; 3) the Pathway Tools Omics Viewer can incorporate
transcriptomic, proteomic, metabolomic and reaction
flux data into the PGDB. It is one of the few tools that
allow integration of metabolic and gene-regulatory net-
works [69], and 4) according to Poolman et al. [70], met-
abolic networks computationally generated from
MetaCyc had lower errors (e.g. unbalanced reactions and
orphan and dead-end metabolites) than those generated
from KEGG. This may be an important feature if the
reconstructed metabolic network is to be further applied
to systems biology.
Despite these strengths, the reconstruction of metabolic
networks using Pathway Tools also has some limitations.
As the automated reconstruction procedure is done by
linking reactions and pathways to annotated genes, the
quality of such an automatically generated metabolic net-
Table 6: List of human genes with no cattle ortholog identified
Gene symbol Gene Name Refseq protein EC number* Entrez-Gene ID
Human Mouse Dog
ECGF1 endothelial cell growth factor 1 (platelet-derived) NP_001944 2.4.2.4 1890 72962 none
CERK ceramide kinase NP_073603; NP_872602 2.7.1.138 64781 223753 474464
FAAH2 fatty acid amide hydrolase 2 NP_777572 3.5.1.4 158584 none none
ALG12 asparagine-linked glycosylation 12 homolog NP_077010 2.4.1.130 79087 223774 481196
EARS2 glutamyl-tRNA synthetase 2, mitochondrial (putative) NP_001077083 6.1.1.17 124454 67417 479807
*Enzyme Commission number
Comparison of constructed 'Cyc' metabolic pathways among cattle, human and E. coli Figure 3
Comparison of constructed 'Cyc' metabolic pathways among cattle, human and E. coli. Numbers of metabolic 
pathways, shared by CattleCyc 1.0, HumanCyc 11.0 and EcoCyc 11.0. The numbers in parentheses are the total number of 
pathways in the corresponding databases. (A) Consensus pathways at the enzyme level (all enzymes in the pathway have the 
same EC numbers). (B) Consensus pathways at the functional level (pathways that share biological function even though indi-
vidual enzymes may differ and alternative reactions may exist).BMC Systems Biology 2009, 3:33 http://www.biomedcentral.com/1752-0509/3/33
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work highly depends on the primary genome annotation
[71]. At present, functions of most mammalian genes are
poorly understood and their annotations are heavily
dependent on sequence homology to human and mouse
[72]. This may lead to limitations in generating species-
specific metabolic networks in mammals. Moreover, due
to the lack of consensus in gene annotations among data-
bases, the amalgamation of functional annotation from
different sources is required.
Another pitfall of the automated reconstruction using
Pathway Tools software is that many inappropriate path-
ways may appear in the reconstructed metabolic network.
Accordingly, the initial reconstruction needs to be manu-
ally curated in a time and labor intensive manner even
though a semi-automated approach to accelerate the
reconstruction process has been developed [71]. This is
mainly because the PathoLogic algorithm was designed to
import as many candidate metabolic pathways from Met-
aCyc as possible for a given gene set, assuming that man-
ual curation is done afterward [16]. Using PathoLogic is
thus a conservative way of reducing the risk of missing
pathways in a genome with an additional payoff in saved
time and labor. Furthermore, the collection of pathways
in MetaCyc is mainly from bacteria [17]. Consequently, a
large proportion of predicted metabolic pathways are bac-
teria-specific that need to be deleted from the automated
reconstruction of eukaryotes unless there is overwhelming
evidence to the contrary. For example, it has been reported
that 126 pathways were deleted and 17 pathways were
manually reconstructed after the initial automated gener-
ation of metabolic pathways of Medicago truncatula [15].
Likewise, in the present study 53% of pathways in the ini-
tial automated reconstruction from cattle PGDB needed
to be deleted or modified. For example, we manually
modified 64 mammalian-specific metabolic pathways
from the reference pathways in MetaCyc and 2 pathways
(Ketogenesis and Ketone degradation) that are important
in lipid metabolism of mammals [73] were added [see
Additional file 2]. Although comprehensive literature
searches and experimentation are the only ways to resolve
false-positives, the addition of mammalian metabolic
pathways reconstructed in this study into MetaCyc will
reduce the effort needed to reconstruct metabolic path-
ways for other mammals.
Another possible way to reduce false-positives in meta-
bolic reconstructions is to categorize pathways in the Met-
aCyc database on the basis of taxonomy and then to use
this information for the computational reconstruction.
For example, peptidoglycan is a unique polymer that
forms an external layer of bacterial plasma membranes
[74]. PathoLogic predicts the presence of the peptidogly-
can biosynthesis pathway in mammals, and HumanCyc
contains this pathway. Similarly, HumanCyc contains
some of the pathways involved in biosynthesis of the
hemi-cellulose components (e.g. rhamnose and arab-
inose) of plants [see Additional file 3]. Classification of
known metabolic pathways that are taxa-specific, and
incorporation of a selection option into PathoLogic, may
reduce the time needed for manual curation and increase
the quality of the automated reconstructions.
Missing enzymes and metabolic pathways were identified
using comparative analysis after automated generation of
the new PGDBs for annotated mammalian genomes
(human, mouse and dog). Comparative analysis of meta-
bolic pathways allowed us to identify unpredicted meta-
bolic pathways of cattle using the automated procedures
and to annotate functions to cattle genes in a metabolism-
centered way. For example, if a metabolic pathway is
present in both cattle and human, a gene involved in an
enzymatic reaction in the human pathway is more likely
present in cattle, and the cattle protein that has the highest
sequence homology to the orthologous human protein is
likely to mediate the reaction. This approach is expected
to facilitate functional annotation of poorly annotated
genomes with greater reliability.
Comparative analysis of metabolic pathways demon-
strated that some metabolic pathways are highly con-
served at both the enzyme and functional levels in cattle
and E. coli [see Additional file 4]. Most highly conserved
pathways are related to nucleotide/nucleoside metabo-
lism and energy metabolism, which are among the most
ancient [75,76]. Some differences in enzymes in the same
functional pathway are related to compartmentation and
localization. For example, gluconeogenesis in mammals
occurs in two compartments, cytosol and mitochondria,
and due to the absence of phosphoenolpyruvate synthase
(EC 2.7.9.2), conversion of pyruvate directly to phos-
phoenolpyruvate does not occur [76]. Instead, pyruvate is
converted to oxaloacetate in mitochondria, where oxaloa-
cetate is decarboxylated into phosphoenolpyruvate by
phosphoenolpyruvate carboxykinase (EC 4.1.1.32) [76].
Distribution of phosphoenolpyruvate carboxykinase
between the cytosol and mitochondria may vary among
mammals [76]. Clearly, if metabolism is to be modeled in
higher organisms with precision, the differences in com-
partmentation of metabolic reactions in plants, animals
and microbes must be better understood.
Although CattleCyc shares only 54% of metabolic path-
ways with HumanCyc (Figure 3), in actuality, few meta-
bolic differences exist between the two species at the
enzyme level on the basis of gene orthology. Upon iden-
tifying and filling pathway holes in the reconstructed cat-
tle metabolic pathways, we found only five missing cattle
orthologs of human genes in the current cattle genome.
This may imply recent metabolic adaptations specific toBMC Systems Biology 2009, 3:33 http://www.biomedcentral.com/1752-0509/3/33
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ruminant artiodactyls. Thus, the differences in metabo-
lism among mammals cannot be fully represented by a
genome-scale global metabolic reconstruction. Neverthe-
less, comparative metabolic pathway analysis establishes
the foundation for studying the evolution of metabolism
and for directing hypothesis-driven research aimed at fill-
ing pathway holes.
We did not find evidence for the existence of mammalian
genes encoding 22 metabolic enzymes for which activity
was reported in the literature. There are two explanations
for these results: 1) incomplete functional annotation of
mammalian genomes and 2) contamination of samples
with enzymes originating from other compartments of
the cell or non-mammals. With respect to the first expla-
nation, even for the human genome, more than 40% of
proteins have not been functionally annotated [77]. Com-
pounding the problem, experimental evidence for meta-
bolic pathways tends to be skewed against less-studied
metabolism [78]. Thus, incomplete annotation is likely to
be the major reason for missing enzymes in metabolic
pathways. Our work clearly identifies and carefully
presents mammalian metabolic pathways and enzymatic
reactions that require experimental validation.
The 'ascorbate biosynthesis' pathway was further investi-
gated as an example of the "missing enzyme" problem
(see [79] for a recent review of ascorbate metabolism).
Except for primates and guinea pigs, which have lost their
ability for ascorbate synthesis due to a highly mutated
gene for L-gulonolactone oxidase [80,81], most mammals
are able to synthesize ascorbate [73]. However, no mam-
malian genes have been identified for the four enzymes in
the pathway (Tables 4 and 5). Thus, there is no genetic evi-
dence for enzymes that catalyze the formation of L-
gulono-1,4-lactone from D-glucuronate in mammals. A
comprehensive literature search revealed that RGN (regu-
calcin; also known as senescence marker protein 30),
which regulates calcium signaling in the liver cell [82],
also has gluconolactonase activity (EC 3.1.1.17) [83].
However, there is no functional annotation of RGN for
this catalytic activity in the NCBI, Ensembl, UniProt or
KEGG databases.
An example of enzyme contamination can be also found
in the ascorbate biosynthesis pathway. Two routes have
been suggested for formation of D-glucuronate from
UDP-glucuronate in mammals [79], either through a for-
mation of D-glucuronate 1-phosphate or β-D-glucuro-
nide. However, the observed pyrophosphatase activity of
rat liver microsomes [84] was likely the result of contam-
ination of the microsomal fraction with plasma mem-
brane fragments [79]. Instead of the above intermediates,
Linster and Schaftingen [85] concluded that UDP-glucur-
onate is directly hydrolyzed to D-glucuronate by a UDP-
glucuronidase. These authors also suggested that UDP-
glucuronidase may be an isoform of UDP-glucuronosyl-
transferase. CattleCyc assumes that D-glucuronate forms
through  β-D-glucuronide as an intermediate because
UDP-glucuronidase has not yet been fully characterized
and there is sufficient evidence that UDP-glucuronosyl-
transferase is involved in the formation of D-glucuronate
[79,86]. These results show that a metabolism-centered
comparative analysis of metabolic pathways is helpful in
identifying and evaluating present gaps in our knowledge.
A well-curated PGDB like CattleCyc will facilitate compu-
tational reconstruction of metabolic pathways for other
mammalian genomes with greater reliability.
Conclusion
A step-wise comprehensive approach was used for the
reconstruction of metabolic pathways of cattle. An amal-
gamated cattle genome database was developed from two
major independent annotation sources, Ensembl and
NCBI, with incorporation of all the available information
for proteins, mainly in UniProt and KEGG. Metabolic
pathways were computationally reconstructed by match-
ing functional annotations of genes to a well-curated bio-
chemical pathways database (MetaCyc). Missing enzymes
and pathways were identified using comparative analysis
and manual curation of the automated reconstruction on
the basis of comprehensive literature searches. Thus we
show that a metabolism-centered comparative analysis of
metabolic pathways is helpful in identifying and evaluat-
ing present gaps in our knowledge. However, metabolic
pathway analysis strongly reflects the quality of the cur-
rent genome annotations and knowledge of compartmen-
talization of metabolic enzymes and functions. Thus,
although most metabolic pathways are shared between
cattle and human at the genomic level, a genome-scale
global metabolic reconstruction does not fully represent
the true metabolic differences between these species. Dif-
ferences in metabolism among mammals may result from
tissue- and organelle-specific transcriptional regulation
and post-transcriptional control mechanisms. Neverthe-
less, comparative metabolic pathway analysis is a power-
ful tool for studying the evolution of metabolic genes and
pathways. The new CattleCyc database will contribute to
understanding the evolution of mammalian metabolism
and the physiology of ruminants at the systems level.
Methods
Development of an amalgamated genome annotation 
database
The NCBI cattle reference build 3.1 and the Ensembl
release 43 build 3.1 were retrieved using Entrez-Gene [87]
and BioMart [88], respectively, on March 2, 2007. The two
data sources were separately used to provide gene models
and basal annotations for the cattle genome. To incorpo-
rate all the known protein names and synonyms as well asBMC Systems Biology 2009, 3:33 http://www.biomedcentral.com/1752-0509/3/33
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EC numbers of gene products, the UniProt accessions and
the Kyoto Encyclopedia of Genes and Genomes (KEGG)
identification (ID) numbers (same as Entrez-Gene ID in
most cases) available for each annotated genome were
matched against those in data flat files retrieved via FTP
on March 2, 2007 from UniProt Knowledgebase release
9.7 [89] and the KEGG Genome Database release 41.0
[90], respectively.
The above NCBI- and Ensembl-based comprehensive cat-
tle genome databases were then integrated in order to
eliminate redundancy, and the amalgamated genome
database was used to generate input files for running Path-
oLogic (see below). For integration, a sequential matching
process was done for all gene pairs that shared a common
(partial or complete) chromosome location, including
those on unassigned contigs. For gene models that had the
same strand and "gene type" (i.e. protein coding, pseudo-
gene, tRNA and miscellaneous RNA), two genes were
assumed to be identical if and only if one or more of the
following conditions was met: 1) gene coordinates were
exactly the same, 2) gene names or synonyms were
matched, 3) Entrez-Gene ID (NCBI) was matched in
Ensembl, 4) gene product names were matched, and 5)
EC numbers that are assigned to the genes were matched.
The matching criteria in the order given above were used
as a regressive scale of confidence in identifying matches.
Matched genes in NCBI and Ensembl were combined into
one gene under the Entrez-Gene ID, with all the associ-
ated annotations incorporated. The smaller coordinate of
the two transcription start sites and the larger of the two
transcription termination sites were assumed as the start
and end coordinates of the final gene model, respectively.
A complete amalgamated cattle genome database contain-
ing all annotations from different sources was created to
facilitate the name matching process during automated
reconstruction. For comparison, the same procedures
were used to generate amalgamated databases for human
(build 36), mouse (build 36) and dog (build 2).
Reconstruction of metabolic pathways
Cattle metabolic pathways were reconstructed from the
amalgamated cattle genome database by generating a cat-
tle-specific PGDB using Pathway Tools 11.0. The initial
cattle PGDB was then manually curated using a compara-
tive analysis approach, which included comparison of
metabolic pathways with other organisms. A generalized
scheme for the metabolism-centered approach is pre-
sented in Figure 1. EcoCyc [13] 11.0 and HumanCyc [9]
11.0 were used as standards for determining the presence
of pathways and enzymes, and new PGDBs for human,
mouse and dog were constructed using the same proce-
dures as described above for the cattle genome. These
automated metabolic reconstructions of the human,
mouse and dog genomes, which were built from the iden-
tical amalgamation process and Pathway Tools, were also
compared with the cattle PGDB. For each pathway pre-
dicted in any species-specific PGDB, biochemical evi-
dence in the literature was searched manually to
determine if the pathway is present in mammals. A path-
way was deleted from CattleCyc after comprehensive liter-
ature search if 1) either the input or the output of the
pathway is not present in any mammal (e.g. peptidogly-
can biosynthesis), or 2) neither enzyme activity was
reported nor homologs were identified in any mammal,
and an alternative pathway exists with strong biochemical
evidence (e.g. putrescien degradation I). When a pathway
present in mammals was not adequately represented in
MetaCyc, it was modified on the basis of information
from KEGG, the literature, and biochemistry text books.
Three data sources were used intensively as references
[73,76,91]. "Missing" metabolic proteins for which no
gene was identified in a cattle pathway were searched for
in the cattle genome and non-redundant protein data-
bases using TBLASTN and BLASTP [92], respectively. The
thresholds used for identification of the cattle ortholog of
a mammalian protein are 80% coverage and 70% iden-
tity, which were similar to those used in the Ensembl gene
annotation [72]. Additional orthologs were assigned if the
best BLAST hit included >50% and exactly matched >90%
of the query protein sequence. Reactions mediated by
those enzymes were also searched for in the literature and
BRENDA [93]. The bioinformatic and biochemical evi-
dence used for gene annotation were referenced and doc-
umented in CattleCyc on the appropriate pages (e.g.,
protein pages and pathway pages). Manual curation of the
human, mouse and dog PGDBs was not performed
because this was beyond the scope of the present work.
Comparative metabolic analysis was done for CattleCyc,
EcoCyc and HumanCyc using the web-server interface
function of PathwayTools followed by manual inspection
to identify metabolic differences among these species.
Availability and requirements
CattleCyc is freely accessible at http://lewin
lab.igb.uiuc.edu/Research/MetabolicReconstruction.html
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PGDB: pathway genome database; EC: enzyme commis-
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Note added in Proof
The most recent release of Human Cyc (12.0) has many
pathways that have been deleted for insufficient evidence,
thus supporting our manual review and curation proce-
dures. In addition, version 11.5 of PathoLogic incorpo-
rates taxonomy-based pathway scoring as suggested in the
Discussion.
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